By Talia Sessel, MSN, APRN, FNP-C A closer look at the microbiome strain linked to metabolic health, insulin sensitivity, and gut barrier integrity and why it may become the next piece of the GLP-1 conversation. GLP-1 medications changed the metabolic health conversation entirely. But the next major development in this space might not come from a pharmacy it might come from your gut microbiome. Meet Akkermansia muciniphila, a strain of gut bacteria that’s increasingly showing
